Growth Metrics

Cytosorbents (CTSO) Net Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -32.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -87.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 42.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -87.88%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -48.90%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 129.29%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -65.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 33.47%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 27.01%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 27.01%
Dec 31, 2025 -69.01%
Sep 30, 2025 30.31%
Jun 30, 2025 49.48%
Mar 31, 2025 33.30%
Dec 31, 2024 31.80%
Sep 30, 2024 14.40%
Jun 30, 2024 54.70%
Mar 31, 2024 -24.37%
Dec 31, 2023 32.84%
Sep 30, 2023 -27.88%
Jun 30, 2023 -38.83%
Mar 31, 2023 -30.44%
Dec 31, 2022 47.40%
Sep 30, 2022 -190.68%
Jun 30, 2022 -56.25%
Mar 31, 2022 -49.29%
Dec 31, 2021 -41.54%
Sep 30, 2021 -136.73%
Jun 30, 2021 -38.94%
Mar 31, 2021 -40.32%
Dec 31, 2020 -119.64%
Sep 30, 2020 275.63%
Jun 30, 2020 -12.87%
Mar 31, 2020 108.30%
Dec 31, 2019 -49.48%
Sep 30, 2019 49.13%
Jun 30, 2019 -38.69%
Mar 31, 2019 -18.23%
Dec 31, 2018 -6.80%
Sep 30, 2018 18.56%
Jun 30, 2018 54.78%
Mar 31, 2018 -18.34%
Dec 31, 2017 -16.55%
Sep 30, 2017 39.05%
Jun 30, 2017 119.01%
Mar 31, 2017 -35.28%
Dec 31, 2016 -134.91%
Sep 30, 2016 -93.52%
Jun 30, 2016 114.52%
Mar 31, 2016 -65.46%
Dec 31, 2015 -87.32%
Sep 30, 2015 -58.66%
Jun 30, 2015 -243.51%
Mar 31, 2015 123.88%
Dec 31, 2014 70.67%
Sep 30, 2014 -59.70%
Jun 30, 2014 -52.25%
Mar 31, 2014 45.26%
Dec 31, 2013 -31.84%
Sep 30, 2013 39.24%